Naghmana Bajwa, M.D.

Recognized as a VIP Member by Strathmore's Who's

Who Worldwide Publication

Long Grove, IL, March 28, 2018 --(PR.com)-- Naghmana Bajwa, M.D. of Long Grove, Illinois has been
recognized as a VIP Member for 2018 by Strathmore's Who's Who Worldwide for her outstanding
contributions and achievements in the field of research & development.

About Naghmana Bajwa, M.D.

Dr. Naghmana Bajwa has almost 20 years experience in the research & development field. She is the
Global Medical Affairs Hematology Lead at Shire, which is a research & development laboratory that
provides research into rare diseases and developing drugs in Chicago, Illinois. She is responsible for
research. Dr. Bajwa assists in the production of drugs that fight diseases related to the blood.

In addition, Dr. Bajwa serves as a Consultant to the Biopharmaceutical Industry through BioNival since
October 2017. She is also a physician and surgical practitioner since January 1990 in Pakistan.

Born on October 12th in Pakistan, Dr. Bajwa obtained a M.D. from Fatima Jinnah Women University
Lahore in Medicine in 1990 and Fatima Jinnah Medical University for General Surgery. Previously, she
served at Parexel, Lidak, Ligand, Matrix in several areas from January 1996 to January 1999. From 1999
to 2000, she served at ISIS Pharmaceuticals as the Director and Head of Global Medical Affairs and
Safety Surveillance. Dr. Bajwa then served as Assistant Director, Head of Global DS Ops and Clinical
Development at Gilead Sciences from October 2003 to December 2005. She was the Director, Head
Global DS, PV, Technical Complaint Groups and Back Up Head Regulatory Medical Lead at Bayer
Health Care, Biologics, Biotach Center of Excellence, CVS Division from June 2005 to June 2009. She
served as the Executive Director, Head of Global Drug Safety, RM, PV and Pharmacoepidemiology
CDMA at AMAG Pharmaceuticals from June 2009 to September 2010. From 2010 to 2012, Dr. Bajwa
was the Senior Director, Pharmacovigilance, Risk Management and Clinical Development at Shire HGT.
She then served as Senior Director, Head Global Safety, PV and Risk Management and Regulatory
Affairs at Janssen Alzheimer Immunotherapy from May 2012 to November 2012. Next, she held the
position of Senior Director, Project Management, Edu/Trng, Risk Management, Safety Review Board and
Medical Services at AbbVie (Abbott Labs) from November 2012 to November 2014. Dr. Bajwa served in
several positons at Shire from October 2015 to October 2017 including Franchise Global Medical Affair
Hemophilia Lead, Head Inhibitors, Senior Medical Director, GMA Hematology Lead, Head Inhibitors,
Blood Disorders portfolios and Elevating Standard of Care.

Dr. Bajwa is affiliated with the A.P.P.N.A., the H.D.A. and the D.I.A. In her spare time she enjoys
baseball, travel, cooking and sewing.

About Strathmore's Who's Who Worldwide

Strathmore's Who's Who Worldwide is an international advertising, networking and publishing company
based in Farmingdale, New York. They are proud to be able to satisfy their clients and continue to have
repeat clientele due to their longevity and pride in their products and services. The Owners strive to
connect business professionals to enhance their contact base and networking capabilities so they can get

Page 1/3
PR.com Press Release Distribution Terms of Use
the acknowledgment and publicity within their industries and beyond. The Strathmore family has been
providing these valuable services for over two decades. They target executives and professionals in all
industries to be featured in their publication and on-line directory. Industries include business, law,
education, healthcare and medicine, fine arts, IT, government, science, real estate, entertainment and
many more accomplished fields. Professional profiles are listed in an annual hardcover journal and in a
detailed, searchable database on the website www.strww.com.

Page 2/3
PR.com Press Release Distribution Terms of Use
Contact Information:
Strathmore Worldwide
Susan Perrault
516-677-9696
Contact via Email
www.strathmoreworldwide.com
Syndi Reibman

Online Version of Press Release:

You can read the online version of this press release at: https://www.pr.com/press-release/748333

Page 3/3
PR.com Press Release Distribution Terms of Use